NuScale Power shares have struggled to break above $10.25, with repeated rallies fading as investors weigh the company’s $750 million at-the-market equity program against its unusually large cash balance. The stock closed at $9.29 on August 29 after falling 4.62%, extending a six-week trading range that has kept the name boxed between roughly $8.80 and $10.25.
The central issue for NuScale Power stock is not just sentiment. It is structure. The company ended the second quarter with about $1.9 billion in cash, cash equivalents, and investments, but that financial cushion has come alongside steep dilution, collapsing revenue, and no signed commercial deployment contract.
For investors, the setup is increasingly clear: NuScale is trading less like a conventional operating company and more like a high-volatility option on one major catalyst, namely a definitive agreement tied to the Tennessee Valley Authority and ENTRA1 Energy.
Key Facts
- NuScale Power closed at $9.29 on August 29 and remains down about 35% year to date, after falling 83.8% from its 52-week high of $57.42.
- Second-quarter revenue fell to $75,000 from $8.05 million a year earlier, a 99.1% year-over-year decline.
- Net loss attributable to Class A shareholders rose to $47.5 million, while the weighted-average Class A share count increased to 364.5 million from 133.4 million a year earlier.
- The company ended the quarter with approximately $1.9 billion in cash, cash equivalents, and short- and long-term investments, versus $1.0 billion at the end of the first quarter.
- NuScale launched a $750 million ATM program on August 11, creating a potential overhang equal to roughly 80.7 million shares at a $9.29 stock price.
NuScale Power Stock
NuScale’s latest quarter highlighted a sharp disconnect between balance-sheet strength and operating performance. Revenue nearly disappeared after work tied to the RoPower project in Romania rolled off, leaving the company with just $75,000 in second-quarter sales. At the same time, research and development spending increased as NuScale continued investing in design maturity, supply chain readiness, and long-lead components for its small modular reactor platform.
That combination matters because NuScale still occupies a rare position in the advanced nuclear sector. It holds the only U.S. Nuclear Regulatory Commission-certified small modular reactor design in the United States, and it received standard design approval for its uprated module in May 2025. In strategic terms, that gives the company a meaningful regulatory moat. In financial terms, however, certification alone does not generate recurring revenue or support valuation if commercial orders remain unsigned.
The market appears to be treating NuScale as a waiting game. Bulls point to the company’s cash-rich balance sheet, low debt, and first-mover regulatory advantage. Bears point to the absence of firm contracts, a first-half operating cash burn of $372.9 million, and a share count that has nearly tripled over the past year. Both views can be true at once: NuScale has strengthened its ability to survive, but shareholders have paid a high price for that runway.
NuScale has the cash, certification, and supply chain to pursue growth, but the stock is unlikely to re-rate sustainably until a signed commercial agreement turns preparation into revenue.
Why $10.25 Has Become a Ceiling
The repeated failure near $10.25 is more than a technical pattern. It reflects a visible supply overhang created by the new ATM facility. An at-the-market program allows a company to issue shares directly into strength, meaning a rising stock price improves the economics of fundraising. Investors understand that dynamic, which can discourage momentum buyers from chasing breakouts.
At current levels, a fully used $750 million ATM would imply substantial additional dilution. Even if management issues stock at higher prices, the program still signals that future rallies may be met with selling pressure. Unless a major contract announcement changes the narrative, resistance near $10 to $10.25 may continue to function as a practical issuance zone rather than a standard chart level.
Implications for Investors
For equity investors, NuScale presents an unusual risk-reward profile. On one hand, the company’s roughly $1.9 billion cash and investment position and debt of only about $6.69 million reduce near-term solvency concerns. That cash reserve gives management time to continue licensing, engineering, and commercial negotiations, particularly around the proposed TVA opportunity, which has been described as potentially involving up to 6 gigawatts of capacity.
On the other hand, investors must weigh that liquidity against burn rate and dilution risk. Annualizing the first-half operating cash outflow of $372.9 million points to roughly $746 million per year, implying about two and a half years of runway at the recent pace before considering further capital raises. The ATM program extends flexibility, but it also threatens to dilute existing shareholders further, especially if commercialization timelines continue to slip.
Portfolio positioning therefore depends on investor mandate and time horizon. For speculative growth investors, NuScale may still appeal as a high-beta advanced nuclear name with a differentiated regulatory asset and a binary contract catalyst. For more conservative investors, the lack of revenue visibility, persistent losses, and dependence on future equity issuance suggest the stock may remain unsuitable until a definitive agreement provides a firmer basis for valuation. Key watch points include progress with ENTRA1 and TVA, any movement on Romania’s RoPower project, the pace of ATM usage, and whether the company can convert supply-chain readiness into signed orders.
NuScale’s next phase will likely be defined less by engineering milestones than by commercial execution. If a binding deployment agreement emerges, the stock could move quickly; if not, the market may continue valuing the company mainly on cash, dilution, and time remaining on the runway.